Secondary Schizophrenia (102 page)

112. Hitomi T., Mezaki T., Tsujii T.,
and adrenomyeloneuropathy.

presenting as neurologically pure

et al.
Improvement of central
J R Soc Med, 1984.
77
:882–4.

familial spastic paraparesis.

motor conduction after bone

92. Sereni C., Ruel M., Iba-zizen T.,
Neurology, 1995.
45
:
marrow transplantation in

et al.
Adult adrenoleuko-

1101–4.

adrenoleukodystrophy. J Neurol

dystrophy: a sporadic case?

254

103. Schwankhaus J. D., Katz D. A.,

Neurosurg Psychiatry, 2003.

J Neurol Sci, 1987.
80
:121–8.

Eldridge R.,
et al.
Clinical and
74
:3:373–5.

Chapter 18 – Psychosis associated with leukodystrophies

113. Spurek M., Taylor-Gjevre R., Van
123. Saraste M. Oxidative

with special reference to

Uum S.,
et al.
Adrenomyelo-

phosphorylation at the fin de

extra-neuromuscular

neuropathy as a cause of primary

siecle. Science, 1999.
283
:1488–93.

abnormalities. Acta Pathol Jpn,

adrenal insufficiency and

124. Lerman-Sagie T., Leshinsky-Silver
1992.
42
:818–25.

spastic paraparesis. Can Med

E., Watemberg N.,
et al.
White
133. Clark J. M., Marks M. P.,

Assoc J, 2004.
171
(9):
matter involvement in

Adalsteinsson E.,
et al.
MELAS:
1073–7.

mitochondrial diseases. Mol Genet

Clinical and pathologic

114. Mukherjee S., Newby E., Harvey J.

and Metab, 2005.
84
:127–36.

correlations with MRI, xenon/CT,

N. Adrenomyeloneuropathy in

125. Kovacs G. G., Hoftberger R.,

and MR spectroscopy. Neurology,

patients with ‘Addison’s disease’:

Majtenyi K.,
et al.
Neuropathology
1996.
46
:223–7.

genetic case analysis. J R Soc Med,

of white matter disease in Leber’s

134. Campos Y., Garcia A., Eiris J.,
2006.
99
:245–9.

hereditary optic neuropathy.

et al.
Mitochondrial myopathy,
115. Castellote A., Vera J., Vasquez E.,
Brain, 2005.
128
:35–41.

cardiomyopathy and psychiatric

et al.
MR in adrenoleuko-

126. Sedel F., Tourbah A., Fontaine B.,
illness in a Spanish family

dystrophy: atypical presentation

et al.
Leukoencephalopathies

harbouring the mtDNA 3303C>T

as bilateral frontal demyelination.

associated with inborn errors of

mutation. J Inherit Metab Dis,

AJNR Am J Neuroradiol, 1995.

metabolism in adults. J Inherit

2001.
24
:685–7.

16
(Suppl 4):814–15.

Metab Dis, 2008.
31
:295–307.

135. Desnuelle C., Pellissier J. F.,
116. Close P. J., Sinnott S. J., Nolan K.

127. Barragan-Campos H. M., Vallee

Serratrice G.,
et al.
Kearns-Sayre
T. Adrenoleukodystrophy: a case

J. N., Lo D., Barrera-Ramirez C. F.,
syndrome: mitochondrial

report demonstrating unilateral

et al.
Brain magnetic resonance
encephalomyopathy caused by

abnormalities. Pediatr Radiol,

imaging findings in patients with

deficiency of the repiratory chain.

1993.
23
:400–1.

mitochondrial cytopathies. Arch

Rev Neurol, 1989.
145
:842–50.

117. MacDonald J. T., Stauffer A. E.,
Neurol, 2005.
62
:737–42.

136. Prayson R. A., Wang N.

Heitoff K. Adrenoleukodystrophy:

128. Anglin R., Mazurek M. F.,

Mitochondrial myopathy,

early frontal lobe involvement on

Noseworthy M.,
et al.
The

encephalopathy, lactic acidosis,

computed tomography. J Comput

psychiatric profile of

and strokelike episodes (MELAS)

Assist Tomogr, 1984.
8
:128–
mitochondrial disorders: clinical

syndrome: an autopsy report.

30.

presentation and MR

Arch Pathol Lab Med, 1998.

118. Young R. S., Ramer J. C., Towfighi
spectroscopy findings. Society for

122
:978–81.

J.,
et al.
Adrenoleukodystrophy:
Neuroscience Annual Meeting, San

137. Sartor H., Loose R., Tucha O., et
unusual computed tomographic

Diego, November 2007.

al. MELAS: a neuropsychological

appearance. Arch Neurol, 1982.

129. Fattal O., Budur K., Vaughan A. J.,
and radiological follow-up study.

39
:782–3.

et al.
Review of the Literature on
Mitochondrial encephalo-

119. Farrell D. F., Hamilton S. R.,

Major Mental Disorders in Adult

myopathy, lactic acidosis and

Krauss T. A.,
et al.
Xlinked
Patients with Mitochondrial

stroke. Acta Neurol Scand, 2002.

adrenoleukodystrophy: adult

Diseases. Psychosomatics, 2006.

106
:309–13.

cerebral variant. Neurology, 1993.

47
:1–7.

138. Lacey C. J., Salzberg M. R.

43
:1518–22.

130. Ahn M. S., Sims K. B., Frazier J. A.

Obsessive-compulsive disorder

120. Moser A. B., Kreiter N., Bezman
Risperidone-induced psychosis

with mitochondrial disease

L.,
et al.
Plasma very long chain
and depression in a child with a

Psychosomatics, 2008.
49
:540–2.

fatty acids in 3,000 peroxisome

mitochondrial disorder. J Child

139. Chinnery P., Majamaa K.,

disease patients and 29,000

Adolesc Psychopharmacol, 2005.

Turnbull D.,
et al.
Treatment for
controls. Ann Neurol, 1999.

15
:520–5.

mitochondrial disorders.

45
:100–10.

131. Apostolova L. G., White M.,

Cochrane Database Syst Rev, 2006.

121. Moser H. W., Raymond G. V., Lu

Moore S. A.,
et al.
Deep white
1:CD004426.

S. E.,
et al.
Followup of 89

matter pathologic features in

140. Brockmann K., Dechent P.,

asymptomatic patients with

watershed regions: a novel of

Wilken B.,
et al.
Proton MRS

adrenoleukodystrophy treated

central nervous system

profile of cerebral metabolic

with Lorenzo’s oil. Arch Neurol,

involvement in MELAS. Arch

abnormalities in Krabbe disease.

2005.
62
:1073–80.

Neurol, 2005.
62
:1154–6.

Neurology, 2003.
60
:819–25.

122. Siva N. Positive effects with

132. Ban S., Mori N., Saito K.,
et al.
An
141. Suzuki K. Twenty five years of the
Lorenzo’s oil (Letter). Lancet,

autopsy case of mitochondrial

“Psychosine Hypothesis”: a

255

2005.
4
:529.

encephalomyopathy (MELAS)

personal perspective of its history

Organic Syndromes of Schizophrenia – Section 3

and present status. Neurochem

Pelizaeus-Merzbacher disease

157. Maurer I., Moller H. G. Inhibition
Res, 1998.
23
:251–9.

phenotype of adult onset, without

of complex 1 by neuroleptics in

142. Suzuki K., Suzuki Y., Suzuki K.

mutation of proteolipid protein

normal human brain cortex

(1995). Galactosylceramide

gene. Acta Neuropathol, 2000.

parallels the extrapyramidal

lipidosis: globoid-cell

99
:7–13.

toxicity of neuroleptics. Mol Cell

leukodystrophy (Krabbe disease).

150. Moghadasian M. H., Salen G.,

Biochem, 1997.
174
:255–9.

In The Metabolic Basis of Inherited

Frohlich J. J.,
et al.

158. Burkhardt C., Kelly J. P., Lim Y.,
Disease, Scriver C. R., Beaudet A.

Cerebrotendinous xanthomatosis:

et al.
Neuroleptic medications
L., Sly W. S.,
et al.
(Eds.). Eighth
a rare disease with diverse

inhibit complex I of the electron

Ed., vol 2. New York:

manifestations. Arch Neurol, 2002.

transport chain. Ann Neurol,

McGraw-Hill, pp. 2671–92.

59
:527–9.

1993.
33
:512–17.

143. Husain A. M., Altuwaijri M.,

151. Moghadasian M. H.

159. Lullman H., Lullman-Ranch R.,

Aldosari M. Krabbe disease:

Cerebrotendinous xanthomatosis:

Wassermann D. Lipidosis induced

neurophysiologic studies and MRI

clinical course, genotypes and

by amphiphilic cationic drugs.

correlations. Neurology, 2004.

metabolic backgrounds. Clin

Biochem Pharmacol, 1978.

63
:617–20.

Invest Med, 2004.
27
:42–50.

27
:1103–8.

144. Lyon G., Hagberg B., Evrard P., et
152. Berginer V. M., Foster N. L.,

160. Shapiro B. E., Hatters-Friedman
al. Symptomatology of late onset

Sadowsky M.,
et al.
Psychiatric
S., Fernandes-Filho J. A.,
et al.

Krabbe’s leukodystrophy: the

disorders in patients with

Late-onset Tay-Sachs disease:

European experience. Dev

cerebrotendinous xanthomatosis.

adverse effects of medications and

Neurosci, 1991.
13
(4–5):
Am J Psychiatry, 1988.
145
:354–7.

implications for treatment.

240–4.

153. Brenner M., Johnson A. B.,

Neurology, 2006.
67
:
145. Escolar M. L., Poe M. D.,

Boespflug-Tanguy O.,
et al.

875–7.

Provenzsale J. M.,
et al.

Mutations in GFAP, encoding glial

161. MacQueen G. M., Rosebush P. I.,
Transplantation of umbilical-cord

fibrillary acidic protein, are

Mazurek M. F. Neuropsychiatric

blood in babies with infantile

associated with Alexander disease.

aspects of the adult-onset

Krabbe’s disease. N Eng J Med,

Nat Genet, 2001.
27
:117–20.

variant of Tay-Sachs disease.

2005.
352
:2069–81.

154. Berger J., Moser H. W.,

J Neuropsychiatry Clin Neurosci,

146. Krivit W., Shapiro E. G., Peters C.,
Forss-Petter S. Leukodystrophies:

1998.
10
:10–19.

et al.
Hematopoietic stem-cell
recent developments in genetics,

162. Neustadt J., Pieczenik S. R.

transplantation in globoid-cell

molecular biology, pathogenesis

Medication-induced

leukodystrophy. N Eng J Med,

and treatment. Curr Opin Neurol,

mitochondrial damage and

1998.
338
:1119–26.

2001.
14
:305–12.

disease. Mol Nutr Food Re, 2008.

147. Koeppen A. H. A brief history of
155. Paloneva J., Kestila M., Wu J.,
52
:780–8.

Pelizaeus-Merzbacher disease and

et al.
Loss-of-function mutations
163. Pacia S. V., Devinsky O.

proteolipid protein. J Neurol Sci,

in TYROBP (DAP12) result in a

Clozapine-related seizures:

2005.
228
:198–200.

presenile dementia with bone

experience with 5,629 patients.

148. Koeppen A. H., Robitaille Y.

cyst. Nat Genet, 2000.
25
:357–
Neurology, 1994.
44
:2247–9.

Pelizaeus-Merzbacher disease.

61.

164. Sevin C., Aubourg P., Cartier N.